Watch our webinar to gain “4 Creative Cost Strategies Changing Healthcare for Good.” You’ll hear healthcare experts from AON, Activate Healthcare, and Paladina Health share key insights on how to reduce employee healthcare expenses.
COVID-19 transformed how we collectively delivered care in 2020. Not only are we seeing an upending of traditional health care settings, but patients increasingly expect to know the costs of their care ahead of time.
Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.
This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the understanding of treatment efficacy